GC Cell Appoints Jeon Ji-won as New Chief BD & Marketing Officer

GC Cell (GC Cell) announced on the 2nd that it has recruited Ji-won Jeon, former leader of oncology and immunology business development at LG Chem, as the Chief BD & Marketing Officer (CBMO) overseeing global business development (BD) and marketing.

Jeon Ji-won, New CBMO of GC Cell
[Photo by GC Cell]

New CBMO Ji-won Jeon majored in human physiology at McGill University in Canada and earned a master's degree from the Graduate School of Biological Sciences at Seoul National University. She has since accumulated diverse experience in oncology global BD and marketing, licensing, mergers and acquisitions (M&A), and post-merger integration (PMI) at companies such as Celltrion, Yuhan Corporation, and Samsung Biologics.

Going forward, CBMO Jeon plans to lead GC Cell’s global BD & marketing division, elevating BD, licensing, and internal and external communications to a global standard, while focusing on maximizing corporate value by collaborating with overseas affiliates.

A GC Cell official stated, “Through new CBMO Jeon, GC Cell plans to establish competitive BD and marketing strategies in the global market, strengthen global business capabilities, and complete a business structure capable of sustainable growth.”

Since early this year, GC Cell has been accelerating its global expansion by consecutively recruiting global talents such as CEO James Park from Samsung Biologics and Chief Technology Officer (CTO) Ho-won Kim from K2B Therapeutics. Through this, the company aims to leap forward as a global top-tier CGT company by declaring a new vision as the ‘Global Creator of Cell & Gene Therapy (CGT).’

This content was produced with the assistance of AI translation services.